Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services
Vitalea Science is a pioneering Bioanalytical Contract Research Organization that provides services to researchers and clinicians in drug development supported by validated Accelerator Mass Spectrometry (AMS) technologies. This method is used in pre-clinic and clinic studies for exploring the behavior of drug candidates in the organism. Due to the AMS device’s ultra-sensitivity it is able to detect C14 tagged molecules in microdose levels. Vitalea also provides AMS services for the characterization and identification of non-medical carbon based compounds.
Vitalea’s scientists include the original developers of AMS technology for applied bioscience at its location in Davis, California near the University of California Davis campus, a leading center for research into AMS, PET tracers and other early phase medical studies.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.